$1.00
0.066.94%
At close: -
$0.9999
-0.000100-0.01%
After Hours: 5:17 PM EDT
Comments
Loading...
PDS Biotechnology Earnings Estimates, EPS & Revenue | NASDAQ:PDSB | Benzinga
PDS Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$-0.330
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of PDS Biotechnology using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PDSB | PDS Biotechnology | -$0.30 | -$0.33 | — | — | $0.00 | — | — | — | 05/14/2025 | Get Alert |
| PDSB | PDS Biotechnology | -$0.35 | -$0.28 | -$0.21 | 25.00% | $0.00 | — | $0.00 | — | 03/27/2025 | Get Alert |
| PDSB | PDS Biotechnology | -$0.35 | -$0.28 | -$0.29 | -3.57% | $0.00 | — | $0.00 | — | 11/14/2024 | Get Alert |
| PDSB | PDS Biotechnology | -$0.37 | -$0.34 | -$0.23 | 32.35% | $0.00 | — | $0.00 | — | 08/13/2024 | Get Alert |
| PDSB | PDS Biotechnology | -$0.32 | -$0.37 | -$0.30 | 18.92% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| PDSB | PDS Biotechnology | -$0.67 | -$0.44 | -$0.35 | 20.45% | $0.00 | — | $0.00 | — | 03/27/2024 | Get Alert |
| PDSB | PDS Biotechnology | -$0.26 | -$0.45 | -$0.35 | 22.22% | $0.00 | — | $0.00 | — | 11/14/2023 | Get Alert |
| PDSB | PDS Biotechnology | -$0.20 | -$0.37 | -$0.37 | 0.00% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| PDSB | PDS Biotechnology | -$0.32 | -$0.31 | -$0.32 | -3.23% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| PDSB | PDS Biotechnology | -$0.23 | -$0.29 | -$0.67 | -131.03% | $0.00 | — | $0.00 | — | 03/28/2023 | Get Alert |
| PDSB | PDS Biotechnology | -$0.24 | -$0.28 | -$0.26 | 7.14% | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
| PDSB | PDS Biotechnology | -$0.03 | -$0.28 | -$0.20 | 28.57% | $0.00 | — | $0.00 | — | 08/08/2022 | Get Alert |
| PDSB | PDS Biotechnology | -$0.14 | -$0.22 | -$0.32 | -45.45% | $0.00 | — | $0.00 | — | 05/11/2022 | Get Alert |
| PDSB | PDS Biotechnology | -$0.16 | -$0.24 | -$0.23 | 4.17% | $0.00 | — | $0.00 | — | 03/31/2022 | Get Alert |
| PDSB | PDS Biotechnology | -$0.23 | -$0.20 | -$0.24 | -20.00% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| PDSB | PDS Biotechnology | -$0.19 | -$0.17 | -$0.03 | 82.35% | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
| PDSB | PDS Biotechnology | -$0.39 | -$0.19 | -$0.14 | 26.32% | $0.00 | — | $0.00 | — | 05/13/2021 | Get Alert |
| PDSB | PDS Biotechnology | -$0.34 | -$0.19 | -$0.16 | 15.79% | $0.00 | — | $0.00 | — | 03/18/2021 | Get Alert |
| PDSB | PDS Biotechnology | -$1.10 | -$0.20 | -$0.23 | -15.00% | $0.00 | — | $0.00 | — | 11/11/2020 | Get Alert |
| PDSB | PDS Biotechnology | -$0.75 | -$0.23 | -$0.19 | 17.39% | $0.00 | — | $0.00 | — | 08/13/2020 | Get Alert |
| PDSB | PDS Biotechnology | -$1.06 | -$0.15 | -$0.39 | -160.00% | $0.00 | — | $0.00 | — | 05/13/2020 | Get Alert |
PDS Biotechnology (PDSB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $-0.21 | $-0.28 | 25.0 % |
| Q3 | 2024-11-14 | $-0.29 | $-0.28 | -3.57 % |
| Q2 | 2024-08-13 | $-0.23 | $-0.34 | 32.4 % |
| Q1 | 2024-05-15 | $-0.30 | $-0.37 | 18.9 % |
PDS Biotechnology (PDSB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is PDS Biotechnology (NASDAQ:PDSB) reporting earnings?
PDS Biotechnology (PDSB) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on March 27, 2025 for Q4.
What were the latest earnings per share (EPS) for PDS Biotechnology (NASDAQ:PDSB)?
The Actual EPS was $-0.21, which beat the estimate of $-0.28.
What were PDS Biotechnology’s (NASDAQ:PDSB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.